Conference Description:

This program will be presented live in-person in Savannah, GA and also is available via livestream EST timezone.

During this 3 day CME course, experts in the field of genetic cardiology and cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of monogenetic, oligogenetic, and polygenic diseases affecting the heart and the blood vessels.

Topics covered will include genetics and genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies.

Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gauge outcome. Two "early bird" special workshops will be conducted to analyze your genetic test reports and to comment on the significance of the genetic test results and the implications for your patients.

Time: 07:00 - 13:00

Prices:
MD, PhD, DO: USD 650.00,
MD, PhD, DO: USD 500.00